U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Wed Apr 02 05:46:34 GMT 2025
Edited
by admin
on Wed Apr 02 05:46:34 GMT 2025
Protein Type BISPECIFIC ANTIBODY
Protein Sub Type IGG4|KAPPA
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
CN0DU4MQE0
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Ubletamig
INN  
Official Name English
H-gamma4 heavy chain anti-MUC16 Homo sapiens (1-455) [VH (Homo sapiens IGHV3-49*04 (93.9%) -(IGHD) -IGHJ6*04 (90.0%) K120>R (121), CDR-IMGT [8.10.20] (26-33.51-60.99-118)) (1-129)-Homo sapiens IGHG4*01 nG4m(a) CH2 L92, 12-G4v5 h P10, 6-G4v7 CH2 delE1.4,
Preferred Name English
Immunoglobulin G4 [237-proline,242-proline,243-valine,244-alanine,de-245-glycine], anti-(human mucin-16) (human monoclonal REGN5668 ?4-chain), disulfide with human monoclonal REGN5668 ?-chain, (235?228?),(238?231?)-bis(disulfide) with immunoglobulin G4 [
Common Name English
ubletamig [INN]
Common Name English
immunoglobulin (H-gamma4_L-kappa)_( H-gamma4_L-kappa), anti-[Homo sapiens MUC16 (mucin 16, MUC-16, cancer antigen 125, CA125)] and anti-[Homo sapiens CD28 (T cell specific surface glycoprotein CD28, TP44)], Homo sapiens monoclonal antibody, bispecific, b
Common Name English
Code System Code Type Description
INN
13410
Created by admin on Wed Apr 02 05:46:34 GMT 2025 , Edited by admin on Wed Apr 02 05:46:34 GMT 2025
PRIMARY
FDA UNII
CN0DU4MQE0
Created by admin on Wed Apr 02 05:46:34 GMT 2025 , Edited by admin on Wed Apr 02 05:46:34 GMT 2025
PRIMARY
CAS
3008247-27-3
Created by admin on Wed Apr 02 05:46:34 GMT 2025 , Edited by admin on Wed Apr 02 05:46:34 GMT 2025
PRIMARY
From To
1_22 1_98
1_156 1_212
1_143 3_215
1_235 2_228
1_238 2_231
1_269 1_329
1_375 1_433
2_22 2_95
2_149 2_205
2_136 4_215
2_262 2_322
2_368 2_426
3_23 3_89
3_135 3_195
4_23 4_89
4_135 4_195
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_305
N 2_298
Related Record Type Details
TARGET->LIGAND
TARGET->LIGAND
Related Record Type Details
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO_ACID_SUBSTITUTION [2_1] N-TERMINUS Q PIDOLIC ACID SZB83O1W42
AMINO ACID REMOVAL [1_455] C-TERMINUS K LYSINE K3Z4F929H6
AMINO ACID REMOVAL [2_448] C-TERMINUS K LYSINE K3Z4F929H6
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL